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Abstract 
Aim and Methods: Although the antimicrobial activity of extracts from several 
mushroom species have been reported, studies with the individual compounds present in 
that extracts are scarce.  Herein, the antimicrobial activity of different phenolic 
compounds identified and quantified in mushroom species from all over the world was 
evaluated. Furthermore, a structure activity relationship (SAR) analysis and molecular 
docking studies were performed, in order to provide insights in the mechanism of action 
of potential antimicrobial drugs for resistant microorganisms.  
Results: 2,4-Dihydroxybenzoic and protocatechuic acids were the phenolic compounds 
with higher activity against the majority of Gram negative and Gram positive bacteria. 
Furthermore, phenolic compounds inhibited more MRSA than methicillin sensible 
Staphylococcus aureus. MRSA was inhibited by 2,4-dihydroxybenzoic, vanillic, 
syringic (MICs=0.5 mg/mL) and p-coumaric (MIC= 1 mg/mL) acids, while these 
compounds at the same concentrations had no inhibitory effects against methicillin 
sensible Staphylococcus aureus.  
Conclusions: The presence of carboxylic acid (COOH), two hydroxyl (OH) groups in 
para and ortho positions of the benzene ring, as also a methoxyl (OCH3) group in the 
meta position seems to be important for anti-MRSA activity. 
Significance and Impact of the Study: Phenolic compounds could be used as 
antimicrobial agents, namely against some microorganisms resistant to commercial 
antibiotics. 
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Introduction 
In recent years, there is an increasing number of reports on phenolic compounds in 
different mushroom species. Phenolic acids including benzoic and cinnamic acid 
derivatives have been pointed out as the most common. Among benzoic acid 
derivatives, p-hydroxybenzoic, protocatechuic, gallic, vannilic and syringic acids were 
identified in different mushroom species (Puttaraju et al. 2006; Kim et al. 2008; Barros 
et al. 2009;  Heleno et al. 2011; Reis et al. 2011; Vaz et al. 2011; Heleno et al. 2012) 
(Table 1). The identification of cinnamic acid and its derivatives such as p-coumaric, o-
coumaric, caffeic, ferulic and chlorogenic acids was also described (Mattila et al. 2001; 
Valentão et al. 2005;  Puttaraju et al. 2006; Barros et al. 2008;  Kim et al. 2008; Heleno 
et al. 2011; Reis et al. 2011; Vaz et al. 2011; Heleno et al. 2012). The presence of some 
flavonoids such quercetin, rutin and chrysin (Valentão et al. 2005; Ribeiro et al. 2006; 
Kim et al. 2008; Jayakumar et al. 2009; Yaltirak et al. 2009) and tannins like ellagic 
acid (Ribeiro et al. 2007) were reported (Table 1).  
In vitro and epidemiologic studies suggest that consumption of foods rich in phenolic 
compounds might significantly decrease the risk of some health problems due to their 
antioxidant, antimutagenic, anti-inflammatory and antibacterial properties (Surh	  2002;	  Albayrak	   et	   al.	   2010). Nowadays, the evidence that the increasing number of 
microorganisms resistant to the available antibiotics is an emergent problem and subject 
for researchers and clinicians from all over the world. In general, it can be observed that 
the treatment of virus, bacteria, fungi and protozoa with the existent drugs is 
increasingly difficult. To overlap the disadvantages of the available antimicrobial drugs, 
other drugs with new mechanisms of action should be developed (Khalafi-Nezhad et al. 
2005).  
Although the antimicrobial activity of extracts from several mushroom species have 
been reported (Barros et al. 2007; Quereshi et al. 2010; Ozen et al. 2011; Alves et al., 
2012), studies with the individual compounds present in that extracts are scarce, being 
mainly related to phenolic compounds identified in plant sources (Kuete et al. 2009; 
Orhan et al. 2010; Lou et al. 2012).  
Therefore, the aim of the present study was to evaluate the antimicrobial activity of 
most relevant compounds identified and quantified in mushroom species from all over 
the world. Furthermore, a structure activity relationship (SAR) analysis and molecular 
docking studies against Penicillin Binding Protein 2a (PBP2a) were performed, in order 
to give insights in the mechanism of action of potential antimicrobial drugs for resistant 
microorganisms. Molecular docking is an in silico tool that predicts how a ligand 
(substrate or drug candidate) interacts with a receptor (e.g. proteins involved in several 
biological processes) and has been successfully applied in several therapeutic programs 
at the lead discovery stage (Ghosh et al. 2006).  
 
Materials and Methods 
 
Standards and reagents  
The culture media Muller Hinton broth (MHB) and Wilkins-Chalgren Broth (WCB) 
were obtained from Biomerieux (Marcy l´ Etoile, France), respectively. The dye p-
iodonitrotetrazolium chloride (INT) was purchased from sigma–Aldrich (Spruce Street; 
St. Louis, USA) to be used as microbial growth indicator. Water was treated in a Milli-
Q water purification system (TGI Pure Water Systems, USA) before use.  
 
Phenolic compounds 
Sixteen phenolic compounds (phenolic acids, flavonoids and tannins) already identified 
in tens of different wild mushroom species by our research group and by others (Table 
1), were submitted to antimicrobial activity evaluation against Gram positive and Gram 
negative bacteria clinical isolates. Compounds were dissolved in water or in water with 
1% DMSO (for flavonoids and tannins), at a concentration of 10 mg/mL, and stored at -
20 ºC for further use (up to 1 week). 
 
Microorganisms and culture media  
The microorganisms used were clinical isolates from patients hospitalized in various 
departments of the Hospital Center of Trás-os-Montes e Alto Douro – Chaves, Portugal. 
Six Gram positive bacteria (methicillin-susceptible Staphylococcus aureus (MSSA) and 
methicillin-resistant Staphylococcus aureus (MRSA) isolated from wound exudates, 
Staphylococcus epidermidis, Enterococcus faecalis and Listeria monocytogenes isolated 
from blood culture, and Streptococcus agalactiae isolated from vaginal swab and five 
Gram negative bacteria (Escherichia coli, Proteus mirabilis and Morganella morganii, 
isolated from urine, Pasteurella multocida isolated from synozial fluid and Neisseria 
gonorrhoeae isolated from urethral exudate) were used to screen the antimicrobial 
activity of the selected phenolic compounds. Escherichia coli showed resistance to 
fluoroquinolones (levofloxacin and ciprofloxacin) and ampicillin, being intermedia for 
amoxicillin/clavulanic acid; Proteus mirabilis was resistant to nalidixic acid, 
levofloxacin, nitrofurantoin, fosfomycin and trimethoprim/sulfasoxazole, and 
intermediate to gentamicin; Morganella morganii showed resistance to ampicillin, 
amoxicillin/clavulanic acid, cephalothin, cefazolin, cefuroxime, nitrofurantoin, 
fosfomycin and trimethoprim /sulfasoxazole; MSSA was only resistant to penicillin and 
ampicillin, while MRSA was resistant to oxacillin, levofloxacin and ciprofloxacin; 
Staphylococcus epidermidis showed resistance to oxacillin and erythromycin. 
All strains were identified using the MicroScan automated methodology - Siemens. 
Muller Hinton broth (MHB) and Wilkins-Chalgren Broth (WCB) were used for 
determination of Minimum Inhibitory Concentration (MIC, lowest concentration of the 
phenolic compound able to completely inhibit bacterial growth). 
 
Test assays for antimicrobial activity 
MIC determinations were performed by the microdilution method and the rapid p-
iodonitrotetrazolium chloride (INT) colorimetric assay following the methodology 
suggested by Kuete et al. (2011) with some modifications. 
Initially, 50 µL of each phenolic compound solution (1mg/mL) filter sterilized was 
diluted in 450 µL of MHB for all microorganisms except for Neisseria gonorheia where 
WCB was used (also with final concentration of 1 mg/mL) and then, 200 µL of this 
solution was added in each well (96-well microplate). Titrations (eight different final 
concentrations) were carried out over the wells containing 100 µL of MHB or WCB and 
afterwards, 10 µL of inoculum (1 ×108 cfu/mL) were added to all the wells. 
Two negative (one with MHB or WCB and the other with the phenolic compound) and 
one positive (with MHB or WCB and the inoculum) controls were performed. The 
plates were incubated at 37 °C, for 24 h, in an oven (Jouan, Berlin, Germany) or with 
humidified atmosphere containing 10% CO2 (NuAire, Plymouth, USA), in the case of 
Neisseria gonorrhoeae.  
The MIC of the samples were detected following addition of INT (0.2 mg/mL, 40 µL) 
and incubation at 37 °C for 30 min. Viable microorganisms reduced the yellow dye to a 
pink colour. MIC was defined as the lowest phenolic compound concentration that 
prevented this change and exhibited complete inhibition of bacterial growth. All the 
assays were carried out in duplicate.  
 
Compounds and protein structure preparation 
ACD/ChemSketch Freeware 12.0 software was used to design 2D structure of the 
compounds. The software VegaZZ 2.3.1 (Pedretti et al. 2004) was then used to convert 
all compounds from 2D to 3D structures. AutoDockTools1.5.2 (ADT) (Sanner 2005) 
was used to merge nonpolar hydrogens, add Gasteiger charges, and set up rotatable 
bonds through AutoTors.  
The crystal structure of PBP2a (Penicillin Binding Protein 2a) was obtained from the 
Protein Data Bank (PDB): 1VQQ (PDB entry) (Lim and Strynadka 2002). The software 
AutoDockTools was also used to assign polar hydrogens, add gasteiger charges and 
save the protein structure in PDBQT file format. AutoGrid4 (Morris et al. 2009) was 
used to create affinity grid maps for all the atoms on the protein and phenolic 
compounds used.  
 
Molecular docking 
AutoDock4 (version 4.2) with the Lamarckian genetic algorithm was used to perform 
the docking studies. Docking parameters selected for AutoDock4 runs were as follows: 
100 docking runs, population size of 200, random starting position and conformation, 
translation step ranges of 2.0 Å, mutation rate of 0.02, crossover rate of 0.8, local search 
rate of 0.06, and 2.5 million energy evaluations. Docked conformations were clustered 
using a tolerance of 2.0 Å RMSD (Root Mean Square Deviation). The molecular 
docking experiments were performed on a dedicated cluster of 64 Core AMD 2.0 GHz, 
running on CentOS and using MOLA, a custom designed software for virtual screening 
using AutoDock (Abreu et al. 2010). All figures with structure representations were 
produced using PyMOL (The PyMOL Molecular Graphics System, Version 1.3, 
Schrödinger, LLC. Available at: (http://www.pymol.org/). 
 
Results  
Table 1 presents phenolic compounds that have been identified in different mushroom 
species from several countries, where it can be observed that different compounds were 
detected in the same species. Several external factors have been pointed to explain this 
fact, such as the heterogeneous enzymatic and oxidative decomposition after collection, 
different stress conditions associated to each sample, and even dissimilar methodologies 
applied to phenolic compounds extraction (Oke and Aslim 2011; Vaz et al. 2011).  
These compounds are well known for their antioxidant properties (Puttaraju et al. 2006; 
Ribeiro et al. 2007; Kim et al. 2008), but they also revealed antimicrobial activity 
(Barros et al. 2007; Quereshi et al. 2010; Schwan et al. 2010; Ozen et al. 2011) 
emerging with potential against multiresistances. Their increasing prevalence is one of 
the major challenges for the healthcare systems worldwide. Antibiotic resistant 
infections are associated with a 1.3 to 2-fold increase in mortality compared to 
antibiotic susceptible infections (Cosgrove and Carmeli 2003). Moreover, antibiotic 
resistance imposes enormous health expenditure due to the higher treatment costs and 
longer hospital stays. In addition, the development of new generations of antibiotic 
drugs is stalling. 
In the present study, in the range of tested concentrations (0.78-1000 µg/mL), 2,4-
dihydroxybenzoic, protocatechuic, vanillic and p-coumaric acids showed antibacterial 
activity (MIC=1 mg/mL) against Escherichia coli, Pasteurella multocida and Neisseria 
gonorrhoeae (Table 2). It should be highlighted that the Escherichia coli isolate used 
herein shows resistance to fluoroquinolones (levofloxacin and ciprofloxacin) and 
ampicillin, being intermedia for amoxicilin/clavulanic acid. Kuete et al. (2009) reported 
a MIC=78 µg/mL for protocatechuic acid isolated from Ficus ovata against Escherichia 
coli (β- lactamases positive). The observed difference in MIC values could be related to 
the use of strains with different susceptibility profiles. Escherichia coli resistance to 
fluoroquinolones and cephalosporins has drastically increased in the last decade (Rogers 
et al. 2011), the mentioned phenolic acids could be an option against this bacteria. 
Recently, Lou et al. (2012) also reported the antimicrobial activity of p-coumaric acid 
(MIC=80 µg/L) against Escherichia coli, but also against other Gram negative bacteria 
such as Salmonella typhimurium and Shigella dysenteriae; this compound changes the 
permeability of the cell membrane and has the capacity to bind DNA inhibiting cell 
function. Other authors (Teke et al. 2011) described the antimicrobial activity of vanillic 
acid against Escherichia coli and Proteus mirabilis, which is in agreement with the 
results reported herein. Moreover, the Proteus mirabilis strain used in the present study 
shows resistance to nalidixic acid, ciprofloxacin, nitrofurantoin, fosfomycin and 
trimethoprim/sulfasoxazole, being intermedia for gentamicin. Nevertheless, it should be 
highlighted that the strains used herein have different antibiotic resistance profiles, 
while the ones used in the mentioned study did not revealed relevant resistances; this 
important feature could be related to the differences observed in MIC values. 
 Despite the absence of reports regarding the presence of 2,4-dihydroxybenzoic acid in 
mushrooms and its antimicrobial activity, due to the chemical similarity with other 
phenolic acids mentioned as antimicrobial compounds, we decided to test it and, as far 
as we know this is the first report on its activity against Gram negative bacteria. 
Gallic acid, ferulic acid and quercetin exhibited activity only against Pasteurella 
multocida and Neisseria gonorrhoeae, and the latter was mainly sensible to quercetin 
(MIC=0.5 mg/mL; Table 2). According to WHO report published in 2001, more than 
six million cases of gonorrhea (infection caused by Neisseria gonorrhoeae) occur in 
each year, and with increasing levels, mostly in developing countries; furthermore, there 
is an emergent resistance of this bacteria to the antimicrobial agents used in gonorrhea 
treatment. Therefore, the mentioned phenolic compounds could be an alternative to be 
explored for the control of this infection. Studies evaluating the antibacterial activity of 
mushroom extracts or isolated compounds against Neisseria gonorrhoeae are scarce, so 
it is important to clarify their mechanism of action upon this microorganism as also in 
other Gram negative cocci.  
Although no activity was observed for rutin against the tested Gram negative bacteria 
(Table 2), other authors (Orhan et al. 2010) reported antimicrobial activity of this 
compound against different strains of Gram negative bacilli, such as Escherichia coli, 
Proteus mirabilis, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter 
baumannii.  
Once more, 2,4-dihydroxybenzoic and protocatechuic acid were the phenolic 
compounds with higher activity against the majority of Gram positive bacteria (Table 
3). Protocatechuic acid showed a MIC of 1 mg/mL for MSSA and MRSA, as also for 
Listeria monocytogenes and Streptococcus agalactiae. Other studies reported the 
antimicrobial activity of this compound against Staphylococcus aureus and with lower 
concentrations (MIC=156 µg/mL; Kuete et al. 2009). Once more, the strain used herein 
was resistant to oxacillin and to both fluoroquinolones (ciprofloxacin and levofloxacin), 
which could be responsible for the higher MIC value observed in comparison to the 
mentioned study.  
Regarding Staphylococcus, ferulic and caffeic acids were the only phenolic compounds 
inhibiting Staphylococcus aureus, MRSA and Staphylococcus epidermidis. 
Nevertheless, other authors reported antimicrobial activity of p-coumaric acid, quercetin 
and rutin against Staphylococcus aureus (Kuete et al. 2009; Orhan et al. 2010; Lou et 
al. 2012). The absence of antimicrobial activity observed in the present study could be 
related to the different dissolution solvent used, water, and not ethanol:hexane and 
Tween 80 as used by the mentioned authors. Nevertheless, some of those solvents might 
have some inherent toxicity and should be carefully used. 
Syringic and ellagic acids showed a MIC of 0.5 mg/mL against Listeria monocytogenes 
(Table 3). Cinnamic acid seemed to be the most active upon Steptococcus agalactiae 
(CMI 0.5 mg/mL) Among all the tested phenolic compounds, only 2,4-
dihydroxybenzoic acid inhibited Enterococcus faecalis (MIC=1 mg/mL); nonetheless, 
other authors described antimicrobial activity of rutin (MIC=128 mg/mL), 
protocatechuic acid (MIC=39 µg/mL) and vanillic acid (zone of inhibition 16 mm) 
(Kuete et al. 2009; Orhan et al. 2010;  Teke et al. 2011). Isolates of Enterococcus 
faecalis and Enterococcus faecium are the third- to fourth-most prevalent nosocomial 
pathogen worldwide; acquired resistance, most prominently to penicilin/ampicillin, 
aminoglycosides (high-level resistance) and glycopeptides are reported in an increasing 
number of isolates, and the therapeutic spectrum in these cases is limited. Therefore, 
therapeutic alternatives to treat infections with multi- and vancomycin-resistant 
enterococci (VRE) are restricted to antibiotics introduced recently into clinical practice 
such as quinupristin/dalfopristin, linezolid, tigecyclin and daptomycin. However, these 
drugs are only approved for certain indications and resistance has already been reported 
(Montero	  et	  al.	  2008;	  Werner	  et	  al.	  2008), which emphasizes the importance of the 
discovery of new alternative drugs.  
It should be notice that the differences among the results reported by several authors 
could be related to the use of strains with different resistance profiles, but also to 
different methodologies used including different solvents for compound solution 
preparation or different techniques to determine MICs. In the present study, water was 
chosen for being the most innocuous solvent; however in the case of flavonoids and 
tannins water with 1% DMSO was used to assure the total solubility of the compounds. 
MRSA has been indicated as one of the major causes of nosocomial infections and its 
increasing prevalence has been observed in the last decade. Furthermore, the treatment 
of MRSA infections is difficult due to the restrict spectra of efficient antibiotics 
(Chambers et al. 2001). The obtained data in the present study (Table 3) show that 
phenolic compounds inhibited more MRSA than methicillin sensible Staphylococcus 
aureus. MRSA was inhibited by 2,4-dihydroxybenzoic, vanillic, syringic (MICs=0.5 
mg/mL) and p-coumaric (MIC= 1 mg/mL) acids, while these compounds at the same 
concentrations had no inhibitory effects against methicillin sensible Staphylococcus 
aureus. Ferulic acid inhibited both MRSA and methicillin sensible Staphylococcus 
aureus, but in a lower concentration for MRSA (Table 3). 
 
Discussion 
Regarding these results, it is interesting to notice that the two Staphylococcus aureus 
tested showed different susceptibility toward the compounds tested, possibly explained 
by the different resistance mechanisms exhibited by each strain. To understand theses 
differential effects, a structure-activity relationship (SAR) study was carried by 
analysing the different chemical structure patterns of the evaluated compounds.  
Only phenolic acids (benzoic and cinnamic acid derivatives) showed activity, 
highlighting the importance of the carboxylic group in the molecule structure (proton 
acceptor). Furthermore, all the compounds with anti-MRSA activity have OH (proton 
donor) and OCH3 (proton acceptor) groups in the para and meta positions of the 
benzene ring, respectively (Table 4).In the absence of OCH3 group in the meta position 
(p-coumaric acid), the activity decreased. Nevertheless, the absence of the mentioned 
group in the structure of 2,4-dihydroxybenzoic acid seemed to be overlapped by the OH 
substitution in ortho position of the benzene ring. Only OCH3 (proton acceptor) or H in 
position 5 of the benzene ring allowed anti-MRSA activity, since when OH is presented 
in that position the activity disappears (see the examples of protocatechuic and gallic 
acids in Table 4). 
MRSA is resistant to all β-lactam antibiotics and this ability is due to the acquisition of 
mecA gene (Lowy 2003). This gene encodes the PBP2a protein and when it is 
challenged by β-lactams, MRSA will use the transpeptidase functionality of PBP2a to 
synthesize the cell wall (Wilke et al. 2005). 
Since the major difference between MSSA and MRSA is mecA, studies of molecular 
docking were performed using 3D crystal structure of PBP2a (PDB:1QVV) as target to 
understand the inhibition mechanism of the phenolic compounds with activity against 
MRSA. The docking results revealed a superimposition of the docking poses for the 
three benzoic acid derivatives (vanillic, 2,4-dihydroxybenzoic and syringic acids) 
(Figure 1). 
The binding pose shows several hydrogen bonds (H-bonds) that validate SAR analysis 
described above. The carboxylic group is stabilized by H-bonds with the amino (NH2) 
group of LYS406 side chain, the hydroxyl (OH) group of SER403 side chain and the 
carbaxamide (NH2CO) group of ASP464 side chain. Furthermore, OH in the para 
position of the benzene ring, which contributes to the anti-MRSA activity of the 
compounds, establishes a hydrogen bond with Serine (SER461) carbonyl group of the 
peptidic bond. The OCH3 group in the meta position of the benzene ring (as in vanillic 
and syringic acids) is stabilized by a hydrogen bond with Glutamate (GLU447) amine 
group of the peptidic bond. The OH in meta position of the benzene ring (as in 2,4-
dihydroxybenzoic acid) is stabilized by a hydrogen bond with Serine (SER462) 
carbonyl group of the peptidic bond. 
 
Overall, 2,4-dihydroxybenzoic, protocatechuic, vanillic and p-coumaric acids were the 
compounds that showed higher antimicrobial activity against Gram positive and 
negative bacteria. Cinnamic acid derivatives revealed higher antimicrobial activity 
against Gram positive and negative coccus.  
The presence of carboxylic acid (COOH), two hydroxyl (OH) groups in para and ortho 
positions of the benzene ring, as also a methoxyl (OCH3) group in the meta position 
seems to play an important role in the studied phenolic compounds anti-MRSA activity. 
The docking studies provided strong evidence that the molecular basis for this activity is 
probably as PBP2a inhibitors. The mentioned compounds could be a solution for 
multiresistance problem, but their mechanism of action in different microorganisms 
should be better understood. 
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Table 1. Phenolic compounds identified in wild mushrooms and submitted to antimicrobial activity evaluation.  
Phenolic compounds Mushroom species Country References 
Phenolic acids: benzoic acid derivatives 
p- Hydroxybenzoic acid Agaricus arvensis, Agaricus bisporus, Agaricus romagnesii, Agaricus silvicola,  
Amanita caesarea, Amanita muscaria, Amanita pantherina, Amanita rubescens,  Armillaria 
mellea,  Auricularia auricula-judae, Boletus aereus, Boletus edulis, Boletus reticulatus, 
Boletus rhodoxanthus, Boletus satanas,  Calocybe gambosa, Cantharellus cibarius, 
Chroogomphus fulmineus,  Citocybe odora,  Coprinus comatus, Cortinarius anomalus, 
Cortinarius collinitus, Cortinarius violaceus,  Craterellus cornocopioides, Fistulina 
hepática,  Ganoderma lucidum, Hygrophorus marzuolus, Hygrophorus olivaceo-albus, 
Ionotus obliquu,  Lactarius deliciosus, Lactarius salmonicolor, Lactarius volemus,  Lepista 
nuda, Lentinus edodes,  Lycoperdon molle, Phellinus linteus,  Pleurotus eryngii, Pleurotus  
ostreatus Ramaria botrytis, Russula cyanoxantha, Sarcodon imbricatus,   Sparassis crispa, 
Suillus granulatus,  Suillus collinitus, Suillus mediterraneensis, Tricholoma acerbum,  
Tricholoma equestre,  Tricholoma sulphureum 
Finland, Korea, 
Portugal,   Spain,  
Turkea  
 
Mattila et al. 2000;  
Ribeiro et al. 2006, 
2007; Kim et al. 2008; 
Barros et al. 2009; 
Heleno et al. 2011; 
2012; Oke et al. 2011; 
Palacios et al. 2011; 
Reis et al. 2011;  
Vaz et al. 2011a, 2011b 
Protocatechuic acid Agaricus bisporus, Agaricus blazei, Amanita caesarea, Amanita pantherina, Auricularia  
polytricha, Boletus edulis, Boletus rhodoxanthus, Boletus satanas,  Cantharellus cibarius, 
Cantherallus clavatus,  Calocybe gambosa, Chroogomphus fulmineus, cortinarius 
anomalus,   Craterellus cornocopioides,  Fistulina hepática, Flammulina velutipes, 
Ganoderma lucidum, Helvella crispa,  Hygrophorus agathosmus,  Hygrophorus marzuolus, 
Hydnum repandum,  Ionotus obliquus,   Lactarius deliciosus, Lactarius sangifluus,  
Lentinus edodes, Lentinus squarrulosus, Lentinus sajor caju,  Lepista nuda,  Macrolepiota 
procera,  Morchella anguiticeps,  Morchella conica, , Mycena haematopus, Pleurotus 
djamor,  Pleurotus eryngii,  Phellinus linteus,  Pleurotus ostreatus, Pleurotus sajor-caju, 
Ramaria botrytis, Russula brevepis, Sparassis crispa, Suillus collinitus, Suillus 
mediterraneensis,  Termitomyces heimii,  Termitomyces microcarpus,  Termitomyces 
mummiformis, Termitomyces shimperi , Termitomyces tylerance  
Finland , India, 
Korea, Portugal,  
Spain 
Puttaraju et al. 2006; 
Kim et al. 2008; Barros 
et al. 2009; Heleno et al. 
2011; Oke et al. 2011; 
Palacios et al. 2011; 
Reis et al. 2011; Vaz et 
al. 2011a 
 
Gallic acid Auricularia auricula-judae,  Agaricus bisporus, Agaricus blazei, Auricularia polytricha, 
Boletus edulis, Calocybe  gambosa, Cantharellus cibarius, Cantherallus clavatus, 
India, Korea, 
Spain  Turkey 
Puttaraju et al. 2006; 
Kim et al. 2008;  
Craterellus cornocopioides, Flammulina velutipes, Ganoderma lucidum, Geastrum 
arinarius, Helvella crispa, Hygrophorus marzuolus, Hydnum repandum,  Ionotus obliquus, 
Lactarius deliciosus, Lactarius sangifluus,  Lentinus edodes,  Lentinus sajor caju, Lentinus 
squarrulosus, Macrolepiota procera,  Morchella anguiticeps, Morchella conica,    
Pleurotus djamor, Pleurotus eryngii, Pleurotus ostreatus,  Phellinus linteus, Pleurotus 
sajor-caju, Russula brevepis,  Russula delica, Sparassis crispa, Termitomyces heimii,  
Termitomyces microcarpus, Termitomyces mummiformis, Termitomyces shimperi, 
Termitomyces tylerance  
Yaltirak et al. 2009; Oke 
et al. 2011; Palacios et 
al. 2011;  
Vanillic acid 
 
Auricularia auricula-judae, Auricularia polytricha, Cantherallus clavatus, Helvella crispa, 
Hydnum repandum, Lactarius sangifluus, Lentinus squarrulosus, Lentinus sajor caju,  
Lycoperdon molle, Macrolepiota procera, Morchella conica, Pleurotus sajorcaju, 
Pleurotus djamor, Pleurotus eryngii, Russula brevepis, Termitomyces heimii, Termitomyces 
microcarpus, Termitomyces shimperi, Tricholoma acerbum 
India, Portugal,  
Turkey 
Puttaraju et al. 2006; 
Barros et al. 2009;   Oke 
et al. 2011  
Syringic acid Agaricus blazei, Cantherallus clavatus,  Auricularia auricula-judae,  
Hydnum repandum, Lactarius sangifluus, Lentinus sajor caju, Macrolepiota procera, 
Morchella conica, Morchella anguiticeps,  Pleurotus eryngii, Pleurotus djamor, Russula 




Puttaraju et al. 2006; 
Kim et al. 2008; Oke et 
al. 2011  
Cinnamic acid and derivatives 
Cinnamic acid Agaricus arvensis, Agaricus bisporus, Agaricus blazei Agaricus silvicola, Agaricus 
romagnesii, Amanita caesarea, Amanita muscaria, Amanita pantherina,  Armillaria mellea, 
Boletus aereus, Boletus edulis, Boletus purpureus, Boletus reticulatus, Boletus 
rhodoxanthus, Boletus satanas,  Calocybe gambosa, Cantharelus cibarius, Cantherallus 
clavatus, Chroogomphus fulmineus, Citocybe odora,  Coprinus comatus,  cortinarius 
anomalus, Cortinarius collinitus, Cortinarius violaceus, Fistulina hepática, Ganoderma 
lucidum,  Hygrophorus agathosmus, Hydnum repandum, Hygrophoropsis aurantiaca, 
Hygrophorus olivaceo-albus, Lactarius aurantiacus, Lactarius quietus, Lactarius 
salmonicolor, Lactarius sangifluus, Lentinus squarrulosus, Lentinus edodes, Lactarius 
volemus, Lycoperdon perlatum, Pleurotus eryngii, 
Macrolepiota prócera,  Mycena haematopus, Pleurotus sajor-caju, Pleurotus djamor, 
Sparassis crispa, Russula caerulea, Russula sardónia,Suillus collinitus, Suillus luteus, 
Suillus mediterraneensis, Termitomyces heimii, Termitomyces mummiformis, Termitomyces 




Mattila et al. 2000; 
Valentão et al. 2005; 
Puttaraju et al. 2006; 
Kim et al. 2008; Barros 
et al. 2009; Heleno et al. 
2011, 2012; Oke et al. 
2011; Reis et al. 2011; 
Vaz et al. 2011a, 2011b 
 
p-Coumaric acid Agaricus arvensis,  Agaricus bisporus, Agaricus silvicola, Amanita muscaria, Amanita India, Korea, Puttaraju et al., 2006;  
pantherina, Boletus aereus, Boletus edulis, Calocybe gambosa, Cantharellus cibarius,  
Chroogomphus fulmineus,  Citocybe odora,  Coprinus comatus, Cortinarius collinitus, 
Fistulina hepática,  Ganoderma lucidum, Geastrum arinarius, Hygrophorus agathosmus,  
Hygrophorus marzuolus, Lactarius sangifluus, Lentinus sajor caju,  Lepista nuda, 
Macrolepiota procera, Pleurotus djamor,  Pleurotus  ostreatus Sparassis crispa, 
Termitomyces heimii, Tricholoma atrosquamosum 
Portugal, Spain Ribeiro et al. 2007; Kim 
et al. 2008; Barros et al. 
2009; Heleno et al. 
2011, 2012; Palacios et 
al. 2011; Reis et al. 
2011; Vaz et al. 2011a, 
2011b 
o-Coumaric acid Ionotus obliquus  Korea Kim et al. 2008 
Caffeic acid Auricularia auricula-judae, Agaricus bisporus, Boletus edulis, Calocybe  gambosa, 
Cantharellus cibarius, Cantherallus clavatus, Fistulina hepática, Flammulina velutipes,  
Hygrophorus marzuolus,, Lactarius sangifluus, Lactarius  deliciosus Lentinus sajor caju, 
Lentinus squarrulosus,  Morchella anguiticeps,   Morchella conica, Macrolepiota procera, 
Phellinus linteus, Pleurotus djamor, Pleurotus eryngii,  
Russula brevepis,   Russula delica,  Sparassis crispa,  Termitomyces heimii,  Termitomyces 
microcarpus,  Termitomyces shimperi Termitomyces tylerance 
India, Korea, 
Portugal, Spain ,  
Turkey 
Valentão et al. 2005; 
Puttaraju et al. 2006; 
Ribeiro et al. 2007; Kim 
et al. 2008;  Yaltirak et 
al. 2009; Oke et al. 
2011; Palacios et al. 
2011 
Ferulic acid Agaricus bisporus, Cantherallus clavatus, Calocybe  gambosa, Cantharellus cibarius, 
Craterellus cornocopioides , Flammulina velutipes, Ionotus obliquus,  Lactarius deliciosus, 
Lactarius sangifluus, Lentinus squarrulosus, Morchella conica, Macrolepiota procera,  
Pleurotus djamor,  Pleurotus  ostreatus Pleurotus sajor-caju, Sparassis crispa, 
Termitomyces heimii, Termitomyces microcarpus, Termitomyces shimperi 
India, Korea,  
Spain 
Puttaraju et al. 2006; 
Kim et al. 2008; 
Palacios et al. 2011  
5-O-cafeoylquinic acid. 
 
Agaricus bisporus, Boletus edulis, Calocybe  gambosa, Cantharellus cibarius,  Flammulina 
velutipes,  Lactarius deliciosus, Pleurotus ostreatus, Phellinus linteus 
Korea, Portugal,  
Spain 
Valentão et al. 2005; 
Kim et al. 2008; 
Palacios et al. 2011  
Flavonoids 
Quercetin Agaricus blazei,   Flammulina velutipes, Ganoderma lucidum,  Ionotus obliquus,   
Sparassis crispa , Suillus luteus, Suillus granulatus 
Korea,  Portugal  Ribeiro et al. 2006; Kim 
et al. 2008  
Rutin Cantharellus cibarius,  Pleurotus ostreatus,  Russula delica India, Turkey  Valentão et al. 2005; 
Jayakumar et al. 2009; 
Yaltirak et al. 2009 
Chrysin Pleurotus ostreatus India  Jayakumar et al. 2009 
Tannins    
Ellagic acid Fistulina hepatica  Portugal Ribeiro et al. 2007 
 
Table 2. MIC values (mg/mL) of wild mushroom phenolic compounds against clinical 







































Benzoic acid derivatives 
p-Hydroxybenzoic acid > 1 > 1 > 1 > 1 > 1 
2,4-Dihydroxybenzoic acid 1 > 1 > 1 1 1 
Protocatechuic acid 1 > 1 > 1 1 1 
Gallic acid > 1 > 1 > 1 1 1 
Vanillic acid 1 1 > 1 1 1 
Syringic acid > 1 > 1 > 1 1 > 1 
Cinnamic acid derivatives 
Cinnamic acid >1 > 1 > 1 > 1 1 
p-Coumaric acid 1 > 1 > 1 1 1 
o-Coumaric acid > 1 > 1 > 1 > 1 > 1 
Caffeic acid > 1 > 1 > 1 1 > 1 
Ferulic acid > 1 > 1 > 1 1 1 
Chlorogenic acid > 1 > 1 > 1 > 1 >1 
Flavonoids 
Quercetin > 1 > 1 > 1 1 0,5 
Rutin > 1 > 1 > 1 > 1 > 1 
Chrysin > 1 > 1 > 1 > 1 > 1 
Tannins 
Ellagic acid > 1 > 1 > 1 1 > 1 
Reference compounds       
Imipenem  ≤ 1 2 4 nt nt 
Ceftriaxon nt nt nt ≤ 1 ≤ 1 
Table 3. MIC values (mg/mL) of the wild mushroom phenolic compounds against 
clinical isolates of Gram positive bacteria. 
 








derivatives       
p-Hydroxybenzoic acid > 1 > 1 > 1 > 1 > 1 > 1 
2,4-Dihydroxybenzoic 
acid  > 1 0.5 > 1 1 > 1 1 
Protocatechuic acid 1 1 > 1 > 1 1 1 
Gallic acid > 1 > 1 > 1 > 1 >1 > 1 
Vanillic acid > 1 0.5 > 1 > 1 1 1 
Syringic acid > 1 0.5 > 1 > 1 0.5 > 1 
Cinnamic acid 
derivatives       
Cinnamic acid > 1 > 1 > 1 > 1 > 1 0.5 
p-Coumaric acid > 1 1 > 1 > 1 >1 > 1 
o-Coumaric acid > 1 > 1 > 1 > 1 > 1 1 
Caffeic acid 1 1 1 > 1 > 1 > 1 
Ferulic acid 1 0.5 1 > 1 > 1 1 
Chlorogenic acid > 1 > 1 > 1 > 1 1 > 1 
Flavonoids       
Quercetin > 1 > 1 > 1 > 1 1 > 1 
Rutin > 1 > 1 > 1 > 1 1 > 1 
Chrysin > 1 > 1 > 1 > 1 > 1 > 1 
Tannins       
Ellagic acid > 1 > 1 > 1 > 1 0.5 > 1 
Reference compounds        
Gentamicin  ≤ 1 4 ≤ 1 nt nt nt 
Penicillin nt nt nt 2 0.25 ≤ 0.03 
MSSA (Methicillin-susceptible Staphylococcus aureus); MRSA (Methicillin-resistant Staphylococcus 
aureus). 
Table 4. Phenolic acids identified in mushrooms submitted to structure activity 






















Benzoic acid derivatives X R 1 R 2 R 3 R 4 
2,4-Dihydroxybenzoic acid COOH OH H OH H 
p-Hydroxybenzoic acid COOH H H OH H 
Protocatechuic acid COOH H H OH OH 
Gallic acid COOH H OH OH OH 
Vanillic acid COOH H OCH3 OH H 












Cinnamic acid derivatives X R1 R2 R3 R4 
Cinnamic acid CHCHCOOH H H H H 
p-Coumaric acid CHCHCOOH H H OH H 
o-Coumaric acid CHCHCOOH OH H H H 
Caffeic acid CHCHCOOH H OH OH  H 
Ferulic acid CHCHCOOH H CH3O OH H 




Figure 1. 2,4-Dihydroxybenzoic acid (orange), syringic acid (yelow) and vanillic acid 
(cyan) docking poses (lines) in PBP2a (carton blue). Hydrogen bonds are present in 
dash. 
 
 
 
 
 
 
 
 
 
